ActiTrexx GmbH | Finanzwire

Basculer en Français

9559	Companies
188835	Keywords
120583	Articles
100786	Press releases

Home
Companies
ActiTrexx GmbH

BRIEF

published on 10/20/2025 at 10:05, 1 month 30 days ago

ActiTrexx Completes Final Patient Treatment in GvHD Therapy Study

Clinical Study Graft-versus-Host Disease Actileucel Immune Therapy Regulatory T Cells
PRESS RELEASE

published on 10/20/2025 at 10:00, 1 month 30 days ago

ActiTrexx completes treatment of last patient with novel regulatory T cell therapy against Graft-versus-Host Disease
ActiTrexx completes treatment of last patient with novel regulatory T cell therapy against Graft-versus-Host Disease. Phase Ib/II study evaluates Actileucel for GvHD prevention

ActiTrexx Graft-versus-Host Disease Regulatory T Cell Therapy Actileucel Phase Ib/II Study
BRIEF

published on 03/19/2024 at 10:05, 1 year 9 months ago

ActiTrexx Initiates Treatment in Graft-versus-Host Disease Study with Novel T Cell Therapy

Clinical Study ActiTrexx Graft-versus-Host Disease Regulatory T Cell Therapy Actileucel
PRESS RELEASE

published on 03/19/2024 at 10:00, 1 year 9 months ago

ActiTrexx treats first patient with novel regulatory T cell therapy against Graft-versus-Host Disease
ActiTrexx GmbH treats first patient with novel regulatory T cell therapy for Graft-versus-Host Disease. Phase Ib/II study evaluates safety and feasibility of Actileucel treatment

Graft-versus-Host Disease Regulatory T Cell Therapy Actileucel ActiTrexx GmbH Phase Ib/II Study

Accesswire

Published on 12/20/2025 at 00:30, 8 hours 58 minutes ago

Alphinat Announces a Profit of $120,155 for Fiscal Year Ended August 31, 2025
Published on 12/19/2025 at 22:00, 11 hours 28 minutes ago

GMV Minerals Inc. Closes Non-Brokered Equity Financing
Published on 12/19/2025 at 18:30, 14 hours 58 minutes ago

Eagle Plains Shareholders Approve all Matters at Annual General Meeting
Published on 12/19/2025 at 14:40, 18 hours 48 minutes ago

Northern Superior Announces Closing of the Arrangement
Published on 12/19/2025 at 13:30, 19 hours 58 minutes ago

Quartz Commences Trading On The OTCQX Best Market Under The Symbol QZMRF

View all ACCESSWIRE

EQS Group

Published on 12/19/2025 at 22:03, 11 hours 25 minutes ago

EAMD: Trading resumes on the Düsseldorf Stock Exchange, lawsuit filed by minority shareholders dismissed, capital increase for investments in drone projects in the defense tech sector
Published on 12/19/2025 at 21:40, 11 hours 48 minutes ago

IMG Saxony-Anhalt: 2026 in Sight - Saxony-Anhalt Sets the Pace for Future Industries
Published on 12/19/2025 at 20:35, 12 hours 53 minutes ago

Nobu Manchester breaks ground as Robert De Niro visits Manchester with Salboy
Published on 12/19/2025 at 20:15, 13 hours 13 minutes ago

CSDS EU RNS Name Changes (19 December 2025)
Published on 12/19/2025 at 19:56, 13 hours 31 minutes ago

Original-Research: European Lithium Limited (von First Berlin Equity Research GmbH): Buy

Les Echos

Published on 12/19/2025 at 08:30, 1 day ago

Share capital decrease by way of treasury shares cancellation
Published on 12/19/2025 at 07:00, 1 day 2 hours ago

EURAZEO ANNOUNCES A SUCCESSFUL TRANSACTION ACCELERATING ITS ASSET ROTATION
Published on 12/18/2025 at 18:30, 1 day 14 hours ago

Schneider Electric completes transaction to acquire remaining 35% stake in existing Indian JV
Published on 12/18/2025 at 17:45, 1 day 15 hours ago

Cie du Bois Sauvage : Cancellation of own shares
Published on 12/18/2025 at 16:31, 1 day 16 hours ago

In Brazil, ENGIE Fully Commissions Serra do Assuruá, Its Largest Wind Complex Worldwide

View all LES ECHOS COMFI WIRE